IPATF News and Press, ImmunoPrecise Antibodies Ltd. From 04/26/19

On Friday, April 26, ImmunoPrecise Antibodies’ subsidiary U-Protein Express disclosed that it’s obtained an exclusive license from Stanford University. The license allows U-Protein Express to manufacture and sell Wnt surrogate Fc. On the news, IPATF stock soared, up nearly 1...

April 26, 2019 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 26, 2019 – Biopharma companies rise and fall on the back of research and development. Success in the biopharma industry has always been about patents. The exclusive right...

ImmunoPrecise Antibodies' Subsidiary U-Protein Express Announces Exclusive Agreement as Global Supplier for Wnt-Surrogate-Fc Growth Factor Canada NewsWire VICTORIA, April 25, 2019 VICTORIA , April 25, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA"...

PHOENIX, April 25, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed ImmunoPrecise Antibodies Ltd. (IPATF) (“the Company”), a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery, to deliver the most therap...

VICTORIA, April 16, 2019 /CNW/ – ImmunoPrecise Antibodies Ltd. (TSX:IPA)(OTC:IPATF)(FRA: TQB2) (the “Company” or “IPA”)announced today that Jennifer Bath, President and CEO of ImmunoPrecise Antibodies, will present at the upcomin...

ImmunoPrecise to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference ImmunoPrecise to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference Canada NewsWire VICTORIA, April 16, 2019 VICTORIA , April 16, 2019 /CNW/ - IMMUNOPR...

ImmunoPrecise Appoints Andy Nixon to Board of Directors Canada NewsWire VICTORIA, April 11, 2019 VICTORIA , April 11, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) announces that it has appointed Andy Nixon ...

ImmunoPrecise Antibodies ( OTCQB:IPATF ) has extended its collaboration with TetraGenetics aimed at the discovery of novel human monoclonal antibodies against three undisclosed ion channels. More news on: ImmunoPrecise Antibodies Ltd., Healthcare stocks news, Read more ...

VICTORIA, April 9, 2019 /CNW/ – ImmunoPrecise (TSX:IPA)(OTC:IPATF)(FRA: TQB2)(the “Company” or “IPA”) is pleased to announce the extension of its collaboration with TetraGenetics, a biopharmaceutical company developing novel therapeutics for autoimm...

TetraGenetics and ImmunoPrecise extend collaboration by signing multi-target service agreement for the Discovery of Therapeutic Antibodies Canada NewsWire VICTORIA, April 9, 2019 VICTORIA , April 9, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") ...